CVS Health Corporation $CVS Shares Purchased by Cullinan Associates Inc.

Posted by Stanley Muller on Nov 8th, 2026

Cullinan Associates Inc. increased its holdings in shares of CVS Health Corporation (NYSE:CVS – Free Report) by 15.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 53,469 shares of the pharmacy operator’s stock after purchasing an additional 7,045 shares during the quarter. Cullinan Associates Inc.’s holdings in CVS Health were worth $4,582,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Kilter Group LLC purchased a new position in CVS Health in the 2nd quarter worth approximately $27,000. J.Safra Asset Management Corp purchased a new stake in CVS Health during the 2nd quarter valued at approximately $30,000. Beaird Harris Wealth Management LLC grew its holdings in CVS Health by 201.0% during the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 195 shares in the last quarter. Timbuktu Capital Management LLC bought a new stake in shares of CVS Health during the second quarter valued at approximately $31,000. Finally, Dunhill Financial LLC bought a new stake in shares of CVS Health during the second quarter valued at approximately $32,000. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on CVS shares. Truist Financial boosted their target price on shares of CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday, July 14th. Evercore reaffirmed an “outperform” rating on shares of CVS Health in a research note on Wednesday. Weiss Ratings downgraded shares of CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, October 9th. Barclays decreased their price target on shares of CVS Health from $108.00 to $107.00 and set an “overweight” rating on the stock in a research note on Thursday. Finally, Leerink Partners dropped their price objective on shares of CVS Health from $112.00 to $104.00 and set an “outperform” rating for the company in a report on Thursday. Twenty-two analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $108.25.

Read Our Latest Stock Analysis on CVS

CVS Health Stock Up 3.0%

Shares of CVS opened at $83.76 on Friday. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.66. The stock has a market capitalization of $107.17 billion, a price-to-earnings ratio of 9.75, a price-to-earnings-growth ratio of 0.76 and a beta of 0.58. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The business’s 50 day simple moving average is $90.37 and its 200-day simple moving average is $88.89.

CVS Health (NYSE:CVS – Get Free Report) last posted its earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.65 by $0.44. The firm had revenue of $108.40 billion during the quarter, compared to analyst estimates of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. CVS Health’s revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period last year, the firm posted $1.60 earnings per share. As a group, equities analysts expect that CVS Health Corporation will post 8.25 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were given a dividend of $0.6650 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.2%. The ex-dividend date was Thursday, October 22nd. CVS Health’s dividend payout ratio is currently 30.97%.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage

Insider Activity at CVS Health

In other CVS Health news, EVP Prem Shah purchased 23,855 shares of the stock in a transaction that occurred on Friday, November 6th. The stock was purchased at an average price of $83.89 per share, with a total value of $2,001,195.95. Following the acquisition, the executive vice president owned 88,516 shares in the company, valued at approximately $7,425,607.24. The trade was a 36.89% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.85% of the company’s stock.

CVS Health Company Profile

(Free Report)

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.